Allstate Corporation’s Veracyte VCYT Stock Holding History

Allstate Corporation’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	+4,250	New	+$178K	﹤0.01%	1253
2022 Q1	–	Sell	-8,132	Closed	-$335K	–	762
2021 Q4	$335K	Sell	8,132 -218	-3%	-$9.63K	0.01%	711
2021 Q3	$388K	Buy	8,350 +1,679	+25%	+$73.3K	0.02%	563
2021 Q2	$267K	Buy	+6,671	New	+$285K	0.01%	672
2021 Q1	–	Sell	-5,939	Closed	-$291K	–	742
2020 Q4	$291K	Sell	5,939 -998	-14%	-$46.2K	0.01%	632
2020 Q3	$225K	Buy	+6,937	New	+$220K	0.01%	629

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allstate Corporation's VCYT Position: Q2 2026 in Review

Allstate Corporation opened a new position in Veracyte (VCYT) in Q2 2026: 4,250 shares worth $250K. The stake represents ﹤0.01% of the portfolio and ranks #1253 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in VCYT as recently as Q4 2021.

Allstate Corporation first reported a position in VCYT in Q3 2020 and has held it in 6 quarters since. The position peaked at $388K in Q3 2021. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Allstate Corporation held 4,250 shares of Veracyte worth $250K as of Q2 2026.
Veracyte was a new Allstate Corporation position in Q2 2026.
Veracyte made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1253 holding.
Allstate Corporation first reported a position in Veracyte in Q3 2020 and has held it in 6 quarters since.
Allstate Corporation's Veracyte position peaked at $388K in Q3 2021.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.